PURPOSE: Perianal perforating disease (PF) has been reported in approximately 15% of children with Crohn's disease (CD). It is unknown whether children who present with PF at the time of diagnosis have a different course than those that develop PF while on therapy. METHODS: From a prospective, single institution observational registry of children diagnosed with CD, we identified children with perianal perforating CD, defined as perianal abscesses and/or fistulae. Patients who presented with perianal perforating CD (PF-CD0) were compared to those who developed perianal perforating CD (PF-CD1) after initial diagnosis. RESULTS: Thirty-eight of 215 (18%) children with CD had PF-CD during a median follow up of 4.5 years. Patients with PF-CD0 (n=26) tended to be more likely male (81% vs. 50%, p=0.07) and younger (9.3 yrs vs. 12.5 yrs, p=0.02). PF-CD1 (n=12) patients were more likely to require diverting ileostomy (42% vs. 8%, p=0.02) and colectomy (33% vs. 4%, p=0.03). Multivariable analysis predicted increased rate of diverting ileostomy in the PF-CD1 group (p=0.007, OR 19.1, 95% CI 1.6-234.8). CONCLUSION: Pediatric CD patients who develop PF while on therapy for CD have a more severe phenotype and are more likely to require diverting ileostomy or colectomy compared to those who present with PF-CD.
PURPOSE: Perianal perforating disease (PF) has been reported in approximately 15% of children with Crohn's disease (CD). It is unknown whether children who present with PF at the time of diagnosis have a different course than those that develop PF while on therapy. METHODS: From a prospective, single institution observational registry of children diagnosed with CD, we identified children with perianal perforating CD, defined as perianal abscesses and/or fistulae. Patients who presented with perianal perforating CD (PF-CD0) were compared to those who developed perianal perforating CD (PF-CD1) after initial diagnosis. RESULTS: Thirty-eight of 215 (18%) children with CD had PF-CD during a median follow up of 4.5 years. Patients with PF-CD0 (n=26) tended to be more likely male (81% vs. 50%, p=0.07) and younger (9.3 yrs vs. 12.5 yrs, p=0.02). PF-CD1 (n=12) patients were more likely to require diverting ileostomy (42% vs. 8%, p=0.02) and colectomy (33% vs. 4%, p=0.03). Multivariable analysis predicted increased rate of diverting ileostomy in the PF-CD1 group (p=0.007, OR 19.1, 95% CI 1.6-234.8). CONCLUSION: Pediatric CD patients who develop PF while on therapy for CD have a more severe phenotype and are more likely to require diverting ileostomy or colectomy compared to those who present with PF-CD.
Authors: David A Schwartz; Edward V Loftus; William J Tremaine; Remo Panaccione; W Scott Harmsen; Alan R Zinsmeister; William J Sandborn Journal: Gastroenterology Date: 2002-04 Impact factor: 22.682
Authors: Marc L Berger; Nancy Dreyer; Fred Anderson; Adrian Towse; Art Sedrakyan; Sharon-Lise Normand Journal: Value Health Date: 2012 Mar-Apr Impact factor: 5.725
Authors: Neera Gupta; Stanley A Cohen; Alan G Bostrom; Barbara S Kirschner; Robert N Baldassano; Harland S Winter; George D Ferry; Terry Smith; Oren Abramson; Benjamin D Gold; Melvin B Heyman Journal: Gastroenterology Date: 2006-04 Impact factor: 22.682
Authors: Michael J Rosen; Dedrick E Moulton; Tatsuki Koyama; Walter M Morgan; Stephen E Morrow; Alan J Herline; Roberta L Muldoon; Paul E Wise; D Brent Polk; David A Schwartz Journal: Inflamm Bowel Dis Date: 2010-03 Impact factor: 5.325
Authors: Corey A Siegel; Lori S Siegel; Jeffrey S Hyams; Subra Kugathasan; James Markowitz; Joel R Rosh; Neal Leleiko; David R Mack; Wallace Crandall; Jonathan Evans; David J Keljo; Anthony R Otley; Maria Oliva-Hemker; Sharmayne Farrior; Christine R Langton; Iwona T Wrobel; Ghassan Wahbeh; J Antonio Quiros; Gary Silber; Ron J Bahar; Bruce E Sands; Marla C Dubinsky Journal: Inflamm Bowel Dis Date: 2010-09-01 Impact factor: 5.325
Authors: Neera Gupta; Alan G Bostrom; Barbara S Kirschner; George D Ferry; Benjamin D Gold; Stanley A Cohen; Harland S Winter; Robert N Baldassano; Oren Abramson; Terry Smith; Melvin B Heyman Journal: Inflamm Bowel Dis Date: 2010-04 Impact factor: 5.325
Authors: Athos Bousvaros; Donald A Antonioli; Richard B Colletti; Marla C Dubinsky; Jonathan N Glickman; Benjamin D Gold; Anne M Griffiths; Gareth P Jevon; Leslie M Higuchi; Jeffrey S Hyams; Barbara S Kirschner; Subra Kugathasan; Robert N Baldassano; Pierre A Russo Journal: J Pediatr Gastroenterol Nutr Date: 2007-05 Impact factor: 2.839
Authors: David J Keljo; James Markowitz; Christine Langton; Trudy Lerer; Athos Bousvaros; Ryan Carvalho; Wallace Crandall; Jonathan Evans; Anne Griffiths; Marsha Kay; Subra Kugathasan; Neal LeLeiko; David Mack; Petar Mamula; M Susan Moyer; Maria Oliva-Hemker; Anthony Otley; Marian Pfefferkorn; Joel Rosh; Jeffrey S Hyams Journal: Inflamm Bowel Dis Date: 2009-03 Impact factor: 5.325
Authors: Nathan P Zwintscher; Puja M Shah; Amit Argawal; Patrick M Chesley; Eric K Johnson; Christopher R Newton; Justin A Maykel; Scott R Steele Journal: Int J Colorectal Dis Date: 2015-05-21 Impact factor: 2.571
Authors: Ben Kang; Jung Eun Kim; Jae Hun Jung; Jae Young Choe; Mi Jin Kim; Yon Ho Choe; Seung Kim; Hong Koh; Yoo Min Lee; Jee Hyun Lee; Yoon Lee; Ji-Hyuk Lee; Hae Jeong Lee; Hyo-Jeong Jang; Youjin Choi; So Yoon Choi; Ju Young Kim; Byung-Ho Choe Journal: Pediatr Gastroenterol Hepatol Nutr Date: 2020-01-09